insights_auto
Why is 524494 down 3,51%?
Dive Deeperchevron_right
524494:BOM
IPCA Laboratories Ltd
1 845,00 INR
arrow_downward
-3,51%(-67,20) 1D
16-окт., 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
1 913,95 INR
High
1 913,95 INR
Low
1 812,60 INR
Mkt. cap
468,21 млд
Avg. vol.
27,90 миң
Volume
12,00 миң
Dividend
0,33%
Quarterly dividend
1,50 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
35,74
52-wk high
2 039,30 INR
52-wk low
1 252,95 INR
EPS
51,63 INR
Shares outstanding
126,35 млн
No. of employees
17 миң
Open
1 913,95 INR
High
1 913,95 INR
Low
1 812,60 INR
Mkt. cap
468,21 млд
Avg. vol.
27,90 миң
Volume
12,00 миң
Dividend
0,33%
Quarterly dividend
1,50 INR
Ex-dividend date
2026-ж., 7-авг.
P/E ratio
35,74
52-wk high
2 039,30 INR
52-wk low
1 252,95 INR
EPS
51,63 INR
Shares outstanding
126,35 млн
No. of employees
17 миң
News stories
From web sources and news partners
Stock Traders Daily
·
4 саат мурун
Understanding Momentum Shifts in (AGIX)
MarketBeat
·
25 мүнөт мурун
Scholastic (NASDAQ:SCHL) Raised to Hold at Wall Street Zen
Yahoo Finance
·
1 саат мурун
The S&P 500's "Average" Year Almost Never Happens. Here's How Often It Actually Lands Near 10%.
MarketWatch
·
1 күн мурун
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees17,2 миң
Founded1949-ж., 19-окт.
Headquarters-
SectorPharmaceutical industry
Websiteipca.com